{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-amendment-no-2-regulations-2024/note",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-amendment-no-2-regulations-2024/note.json",
  "legislation": "uksi/2024/894",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2024",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-amendment-no-2-regulations-2024",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Regulations)\nThese Regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (“the PLPS Regulations”). The PLPS Regulations govern the arrangements in England, under Part 7 of the National Health Service Act 2006 (“the 2006 Act”), for the provision of pharmaceutical and local pharmaceutical services.\nThe scheme for paying for NHS pharmaceutical and local pharmaceutical services is predicated on the basis that pharmaceutical remuneration that relates to prescription items will ordinarily include an amount which is in respect of (but ordinarily slightly more than) the price that a service provider paid when they purchased a prescription item that they go on to supply or administer. However, there are powers in Part 7 of the 2006 Act to enable alternatives to these ordinary remuneration arrangements in some circumstances. These Regulations amend the alternative arrangements that already allow a zero or nominal NHS reimbursement price to be set for centrally purchased coronavirus, respiratory syncytial virus and measles, mumps and rubella vaccines so that they also apply to centrally purchased pertussis (whooping cough) vaccines (regulation 2).\nThe PLPS Regulations include the terms of service on which community pharmacies that are on pharmaceutical lists held by NHS England, or that have local pharmaceutical services contacts with NHS England, provide NHS pharmaceutical services. Those terms of service are amended to allow a community pharmacy to provide a different quantity of a prescription item to that ordered on an NHS prescription, provided it is no more than 10% greater or less than the quantity ordered, subject to exceptions (regulations 4 and 5).\nThe applications process for inclusion on a pharmaceutical list of authorised providers – either as a community pharmacy or as a dispensing appliance contractor – is changed so that references no longer need to be provided in respect of specified pharmacists – and thereafter taken up and checked. There is a transitional provision for applications submitted before the new arrangements come into force, which amongst other matters allows NHS England to continue to have regard to references already received and to base requests for further information on such references (regulation 3).\nAn assessment of the effect of this instrument was undertaken and it was deemed that a full impact assessment would not be proportionate. These Regulations are not expected to have a significant impact on the public and voluntary sectors, and only a limited impact on the private sector, below the threshold for undertaking a full impact assessment.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2024/894/note",
    "retrieved_at": "2026-10-28T21:27:03.787870+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}